report cover1

Chronic Kidney Disease Drugs Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Kidney disease can affect the body’s ability to clean blood, filter extra water out of blood, and help control blood pressure. It can also affect red blood cell production and vitamin D metabolism needed for bone health. When kidneys are damaged, waste products and fluid can build up in the body. That can cause swelling in ankles, nausea, weakness, poor sleep, and shortness of breath. Without treatment, the damage can get worse and kidneys may eventually stop working. That’s serious, and it can be life-threatening. There are different types of kidney diseases such as chronic kidney disease where kidneys can’t filter toxins or extra fluid from blood. Chronic kidney disease can get worse a times. Polycystic kidney disease is a genetic disorder that causes cysts to grow on the kidneys. Lupus nephritis occurs when the immune system attacks the kidneys. Interstitial nephritis happens when a bad reaction to medicines limits the kidney’s ability to filter toxins. Glomerular disease happens when inflammation in the glomeruli. APOL1- mediated kidney disease. Pyelonephritis is a urinary tract infection within the kidneys.

High blood pressure makes chronic kidney disease more likely and kidney disease can affect blood pressure so in this type ACE inhibitors, such as captopril, enalapril, fosinopril, lisinopril, ramipril, and ARBs, such as azilsartan, eprosartan, irbesartan, losartan, Olmesartan, valsartan along with controlling blood pressure, these medicines may lower the amount of protein in urine. Cholesterol-lowering medications such as statins can be given in the case of people with chronic kidney diseases. Urate-lowering therapy in which uric acid salts can build up in the blood as a result of poor kidney function. Medications like allopurinol lower the level of uric acid to help prevent gout.

Global Chronic Kidney Disease Drugs Market – Competitive Landscape

On September 13, 2023, Mironid, a biopharmaceutical company raised USD 38.04 million to develop a treatment for life-threatening kidney disease. On January 12, 2023, Novartis bought Chinook for up to USD 3.5 billion to get IgAN/Kidney disease medicines. On January 9, 2023, chronic kidney disease and end-stage renal disease management company Monogram Health announced it had scored a whooping USD 375 million in growth funding. On August 30, 2022, InterWell Health completed a three-way merger with Fresenius Health Partners and Cricket Health to create a kidney care powerhouse on track to have USD 11 billion in costs under management by 2025.

Some of the Key Players in the Global Chronic Kidney Disease Drugs Market Include –

  • Sanofi
  • Amgen
  • AstraZeneca
  • Entia
  • Somatus
  • Hoffman-La Roche
  • Regeneron Pharmaceuticals
  • Biogen
  • Pfizer
  • AbbVie
  • Bayer AG

Global Chronic Kidney Disease Drugs Market – Growth Drivers

The global increase in the prevalence of CKD, linked to factors like diabetes and hypertension, is driving demand for effective drugs. According to the National Center for Biotechnology Information (NCBI), the global estimated prevalence of CKD is 13.4%, and patients with end-stage kidney disease needing renal replacement therapy are estimated between 4.902 and 7.083 million. The aging demographic contributes to a higher incidence of CKD, fostering a sustained market for drugs catering to age-related renal conditions. Ongoing research and development are leading to the introduction of novel drugs and therapies, offering improved treatment options for CKD patients. Greater awareness campaigns and emphasis on early diagnosis are fostering a proactive approach to CKD management, spurring demand for pharmaceutical interventions. Supportive government policies, initiatives, and funding for kidney health are positively influencing the CKD drugs market, encouraging research and accessibility. Advances in drug delivery technologies enhance the effectiveness and convenience of CKD drugs, contributing to market growth. The expanding availability of dialysis and transplantation services globally creates synergies with drug therapies, supporting a comprehensive approach to CKD management. The trend toward personalized medicine drives the development of tailored treatments, potentially improving outcomes for CKD patients.

Global Chronic Kidney Disease Drugs Market – Restraints

The extensive research and development process for kidney disease drugs often incurs high costs, acting as a restraint on the market of kidney disease drugs. Strict regulatory requirements and lengthy approval processes can slow down the introduction of new drugs, posing a challenge for the kidney disease drugs market. Despite advancements, there is still a limited number of effective treatment options for certain kidney diseases, restricting the range of available pharmaceutical interventions. Potential side effects and safety concerns associated with some kidney disease drugs may impede patient acceptance and adherence to treatment plans. Economic fluctuations and uncertainties can impact healthcare budgets, potentially limiting investment in kidney disease drug research and development. According to the Centers for Disease Control and Prevention Medicare beneficiaries with CKD cost USD 87.2 billion, and treating people with ESRD costs an additional USD 37.3 billion.  Disparities in access to healthcare services globally may hinder patients from receiving timely diagnosis and appropriate treatment, affecting the market for kidney disease drugs.

Global Chronic Kidney Disease Drugs Market – Opportunities

Ongoing research efforts are driving the development of new drugs for kidney diseases, creating opportunities for pharmaceutical companies. The rising incidence of kidney disorders globally provides a growing market for drugs addressing various renal conditions. With an aging demographic, there’s an increasing demand for drugs targeting age-related kidney ailments contributing to market expansion. Rising awareness about kidney health and the importance of early diagnosis is creating a demand for drugs that effectively treat renal conditions. The shift towards personalized medicine opens doors for tailored treatments, potentially enhancing drug efficacy and patient outcomes in kidney disease. The introduction of innovative therapies and treatment modalities offers opportunities for pharmaceutical companies to address unmet needs kidney disease drugs market.

Global Chronic Kidney Disease Drugs Market – Geographical Insight

The market for global chronic kidney disease drugs is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for chronic kidney disease drugs well-established healthcare infrastructure and a high prevalence of CKD contribute to a significant market share. Increasing awareness and a focus on advanced treatment options characterize this region. Europe’s aging population and government initiative for kidney health make Europe a key market. Collaborative research efforts and advancements in treatment options contribute to market expansion. Asia-Pacific’s rapidly increasing of CKD, particularly in countries with large populations such as China and India, drives the chronic kidney disease drug market growth. Improving healthcare infrastructure and rising disposable income contribute to expanding opportunities.

Chronic Kidney Disease Drugs Market – Key Development

  • On October 18, 2023, the US FDA approved Ardelyx’s kidney disease-related drugs.
  • On September 22, 2023, US FDA approved Jardiance® for the treatment of adults with chronic kidney disease.
  • On July 13, 2023, TheracosBio teams with Mark Cuban’s cost plus to launch Brenzavvy at a bargain price.
  • On February 17, 2023, With FDA approval for Filspari, Travere turns Bristol Myers castoff into a unique drug for rare kidney disease.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert